Rituximab Improves Rate and Duration of Chemotherapy-Induced Remissions in Indolent and Aggressive Non-Hodgkin's Lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lymphoma 2004-09, Vol.5 (2), p.81-83
Hauptverfasser:	Gibson, Angelia D., Jain, Vinay K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Humans Lymphoma, B-Cell - drug therapy Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Non-Hodgkin - drug therapy Middle Aged Random Allocation Remission Induction Rituximab Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!